← Back to headlines
DexCom and Insulet Receive 'Buy' Ratings from Deutsche Bank Despite Recent Selloff
Despite a recent market selloff, DexCom and Insulet have received 'Buy' ratings from Deutsche Bank, indicating confidence in their stock performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
